TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs1419638
log Bayes Factor = 56.0073
Chromosome 6   position 29,355,519  (GRCh37) Explore rs1419638 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E10.9 Without complications
0.000 0.000 1.000
E83.1 Disorders of iron metabolism
1.000 0.000 0.000
K90.0 Coeliac disease
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.001 0.999
E10.3 With ophthalmic complications
0.000 0.001 0.999
E14 Unspecified diabetes mellitus
0.000 0.002 0.998
E10.1 With ketoacidosis
0.000 0.011 0.989
E14.3 With ophthalmic complications
0.000 0.014 0.986
E10.2 With renal complications
0.000 0.015 0.985
E13 Other specified diabetes mellitus
0.000 0.043 0.957
E14.9 Without complications
0.000 0.049 0.951
E10.4 With neurological complications
0.000 0.070 0.930
E13.9 Without complications
0.000 0.070 0.930
E10.0 With coma
0.000 0.122 0.878
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.165 0.834
E14.6 With other specified complications
0.000 0.184 0.816
E14.2 Withrenal complications
0.000 0.185 0.815
E10.6 With other specified complications
0.000 0.185 0.815
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.204 0.796
K90 Intestinal malabsorption
0.000 0.217 0.783
E20-E35 Disorders of other endocrine glands
0.000 0.225 0.775
E16 Other disorders of pancreatic internal secretion
0.000 0.232 0.768
E00-E07 Disorders of thyroid gland
0.000 0.245 0.755
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.249 0.751
E14.4 With neurological complications
0.000 0.251 0.749
E24 Cushing's syndrome
0.000 0.258 0.742
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.258 0.742
E27 Other disorders of adrenal gland
0.000 0.273 0.727
K90.9 Intestinal malabsorption, unspecified
0.000 0.276 0.724
E10.7 With multiple complications
0.000 0.283 0.717
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.716
E05.9 Thyrotoxicosis, unspecified
0.000 0.283 0.717
E14.7 With multiple complications
0.000 0.285 0.715
E14.0 With coma
0.000 0.285 0.715
E16.2 Hypoglycaemia, unspecified
0.000 0.294 0.706
E13.8 With unspecified complications
0.000 0.314 0.686
E13.7 With multiple complications
0.000 0.314 0.686
E13.6 With other specified complications
0.000 0.314 0.686
E13.5 With peripheral circulatory complications
0.000 0.314 0.686
E13.4 With neurological complications
0.000 0.314 0.686
E13.2 With renal complications
0.000 0.314 0.686
E13.1 With ketoacidosis
0.000 0.314 0.686
E13.0 With coma
0.000 0.314 0.686
E14.8 With unspecified complications
0.000 0.321 0.679
E24.9 Cushing's syndrome, unspecified
0.000 0.321 0.679
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.326 0.674
E27.1 Primary adrenocortical insufficiency
0.000 0.333 0.667
E14.1 With ketoacidosis
0.000 0.338 0.661
E13.3 With ophthalmic complications
0.000 0.340 0.660
E14.5 With peripheral circulatory complications
0.000 0.341 0.658
E10.8 With unspecified complications
0.000 0.343 0.657
E10.5 With peripheral circulatory complications
0.000 0.357 0.642
E20 Hypoparathyroidism
0.000 0.374 0.626
E23 Hypofunction and other disorders of pituitary gland
0.000 0.380 0.620
E24.2 Drug-induced Cushing's syndrome
0.000 0.382 0.618
E40-E46 Malnutrition
0.000 0.383 0.617
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.389 0.611
E24.0 Pituitary-dependent Cushing's disease
0.000 0.390 0.610
E16.1 Other hypoglycaemia
0.000 0.391 0.608
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.400 0.600
E27.8 Other specified disorders of adrenal gland
0.000 0.412 0.588
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.416 0.584
E15 Nondiabetic hypoglycaemic coma
0.000 0.429 0.571
K90.3 Pancreatic steatorrhoea
0.000 0.439 0.561
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.439 0.561
K90.1 Tropical sprue
0.000 0.439 0.561
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.444 0.556
E32 Diseases of thymus
0.000 0.444 0.556
E30 Disorders of puberty, not elsewhere classified
0.000 0.444 0.556
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.445 0.555
E29 Testicular dysfunction
0.000 0.445 0.555
E25 Adrenogenital disorders
0.000 0.445 0.555
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.449 0.551
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.449 0.551
E16.4 Abnormal secretion of gastrin
0.000 0.449 0.551
E16.3 Increased secretion of glucagon
0.000 0.449 0.551
E05.8 Other thyrotoxicosis
0.000 0.451 0.549
K90.8 Other intestinal malabsorption
0.000 0.452 0.548
E50-E64 Other nutritional deficiencies
0.000 0.458 0.542
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.458 0.541
E00 Congenital iodine-deficiency syndrome
0.000 0.458 0.541
E05.5 Thyroid crisis or storm
0.000 0.461 0.539
E05.4 Thyrotoxicosis factitia
0.000 0.461 0.539
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.461 0.539
E31 Polyglandular dysfunction
0.000 0.463 0.537
E24.8 Other Cushing's syndrome
0.000 0.468 0.532
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.468 0.532
E24.3 Ectopic ACTH syndrome
0.000 0.468 0.532
E24.1 Nelson's syndrome
0.000 0.468 0.532
E27.5 Adrenomedullary hyperfunction
0.000 0.479 0.521
E27.0 Other adrenocortical overactivity
0.000 0.479 0.521
E20.9 Hypoparathyroidism, unspecified
0.000 0.481 0.519
E23.2 Diabetes insipidus
0.000 0.484 0.516
E23.0 Hypopituitarism
0.000 0.484 0.516
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
E28 Ovarian dysfunction
0.000 0.510 0.490
E27.9 Disorder of adrenal gland, unspecified
0.000 0.512 0.488
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.520 0.479
E26 Hyperaldosteronism
0.000 0.524 0.476
E34 Other endocrine disorders
0.000 0.538 0.462
E46 Unspecified protein-energy malnutrition
0.000 0.539 0.461
E22 Hyperfunction of pituitary gland
0.000 0.547 0.453
E20.8 Other hypoparathyroidism
0.000 0.551 0.449
E20.1 Pseudohypoparathyroidism
0.000 0.551 0.449
E20.0 Idiopathic hypoparathyroidism
0.000 0.551 0.449
E06 Thyroiditis
0.000 0.555 0.445
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.555 0.445
E23.1 Drug-induced hypopituitarism
0.000 0.555 0.445
E61 Deficiency of other nutrient elements
0.000 0.557 0.443
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.558 0.442
E45 Retarded development following protein-energy malnutrition
0.000 0.558 0.442
E43 Unspecified severe protein-energy malnutrition
0.000 0.558 0.442
E42 Marasmic kwashiorkor
0.000 0.558 0.442
E41 Nutritional marasmus
0.000 0.558 0.442
E40 Kwashiorkor
0.000 0.558 0.442
E27.2 Addisonian crisis
0.000 0.566 0.434
E23.7 Disorder of pituitary gland, unspecified
0.000 0.569 0.430
E56 Other vitamin deficiencies
0.000 0.591 0.409
E03 Other hypothyroidism
0.000 0.594 0.406
E30.9 Disorder of puberty, unspecified
0.000 0.601 0.398
E30.8 Other disorders of puberty
0.000 0.601 0.398
E30.1 Precocious puberty
0.000 0.601 0.398
E30.0 Delayed puberty
0.000 0.601 0.398
E32.9 Disease of thymus, unspecified
0.000 0.601 0.398
E32.8 Other diseases of thymus
0.000 0.601 0.398
E32.1 Abscess of thymus
0.000 0.601 0.398
E32.0 Persistent hyperplasia of thymus
0.000 0.601 0.398
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.601 0.398
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.601 0.398
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.601 0.398
E29.9 Testicular dysfunction, unspecified
0.000 0.602 0.398
E29.8 Other testicular dysfunction
0.000 0.602 0.398
E29.0 Testicular hyperfunction
0.000 0.602 0.398
E25.9 Adrenogenital disorder, unspecified
0.000 0.602 0.398
E25.8 Other adrenogenital disorders
0.000 0.602 0.398
E29.1 Testicular hypofunction
0.000 0.602 0.397
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.603 0.397
E07 Other disorders of thyroid
0.000 0.607 0.393
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.611 0.389
E51 Thiamine deficiency
0.000 0.611 0.389
E50 Vitamin A deficiency
0.000 0.611 0.389
E60 Dietary zinc deficiency
0.000 0.611 0.389
E59 Dietary selenium deficiency
0.000 0.611 0.389
E54 Ascorbic acid deficiency
0.000 0.611 0.389
E52 Niacin deficiency [pellagra]
0.000 0.611 0.389
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.612 0.388
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.612 0.388
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.612 0.388
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.612 0.388
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.612 0.388
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.612 0.388
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.612 0.388
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.612 0.388
E31.9 Polyglandular dysfunction, unspecified
0.000 0.615 0.385
E31.8 Other polyglandular dysfunction
0.000 0.615 0.385
E31.1 Polyglandular hyperfunction
0.000 0.615 0.385
E61.2 Magnesium deficiency
0.000 0.625 0.375
E06.9 Thyroiditis, unspecified
0.000 0.626 0.374
E31.0 Autoimmune polyglandular failure
0.000 0.634 0.366
E53 Deficiency of other B group vitamins
0.000 0.636 0.364
E22.0 Acromegaly and pituitary gigantism
0.000 0.641 0.359
E58 Dietary calcium deficiency
0.000 0.643 0.357
E28.2 Polycystic ovarian syndrome
0.000 0.647 0.353
E28.9 Ovarian dysfunction, unspecified
0.000 0.649 0.351
E28.8 Other ovarian dysfunction
0.000 0.649 0.351
E28.1 Androgen excess
0.000 0.649 0.351
E28.0 Oestrogen excess
0.000 0.649 0.351
E63 Other nutritional deficiencies
0.000 0.656 0.344
E26.9 Hyperaldosteronism, unspecified
0.000 0.659 0.341
E26.8 Other hyperaldosteronism
0.000 0.659 0.341
E26.1 Secondary hyperaldosteronism
0.000 0.659 0.341
E22.1 Hyperprolactinaemia
0.000 0.661 0.339
E55 Vitamin D deficiency
0.000 0.664 0.336
E03.8 Other specified hypothyroidism
0.000 0.665 0.335
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.668 0.332
E34.5 Androgen resistance syndrome
0.000 0.668 0.331
E34.4 Constitutional tall stature
0.000 0.668 0.331
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.668 0.331
E34.1 Other hypersecretion of intestinal hormones
0.000 0.668 0.331
E23.6 Other disorders of pituitary gland
0.000 0.670 0.330
E34.8 Other specified endocrine disorders
0.000 0.671 0.328
E53.9 Vitamin B deficiency, unspecified
0.000 0.674 0.325
E22.8 Other hyperfunction of pituitary gland
0.000 0.675 0.325
E06.4 Drug-induced thyroiditis
0.000 0.681 0.319
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.681 0.319
E06.1 Subacute thyroiditis
0.000 0.681 0.319
E06.0 Acute thyroiditis
0.000 0.681 0.319
E34.3 Short stature, not elsewhere classified
0.000 0.682 0.318
E61.9 Deficiency of nutrient element, unspecified
0.000 0.682 0.318
E61.8 Deficiency of other specified nutrient elements
0.000 0.682 0.318
E61.7 Deficiency of multiple nutrient elements
0.000 0.682 0.318
E61.6 Vanadium deficiency
0.000 0.682 0.318
E61.5 Molybdenum deficiency
0.000 0.682 0.318
E61.4 Chromium deficiency
0.000 0.682 0.318
E61.3 Manganese deficiency
0.000 0.682 0.318
E61.0 Copper deficiency
0.000 0.682 0.318
E44.1 Mild protein-energy malnutrition
0.000 0.683 0.317
E44.0 Moderate protein-energy malnutrition
0.000 0.683 0.317
E56.1 Deficiency of vitamin K
0.000 0.687 0.313
E61.1 Iron deficiency
0.000 0.687 0.313
E34.9 Endocrine disorder, unspecified
0.000 0.692 0.307
E34.0 Carcinoid syndrome
0.000 0.706 0.294
E56.9 Vitamin deficiency, unspecified
0.000 0.707 0.293
E56.8 Deficiency of other vitamins
0.000 0.707 0.293
E56.0 Deficiency of vitamin E
0.000 0.707 0.293
E03.5 Myxoedema coma
0.000 0.709 0.291
E03.4 Atrophy of thyroid (acquired)
0.000 0.709 0.291
E03.3 Postinfectious hypothyroidism
0.000 0.709 0.291
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.709 0.291
E06.5 Other chronic thyroiditis
0.000 0.711 0.288
E03.1 Congenital hypothyroidism without goitre
0.000 0.712 0.288
E28.3 Primary ovarian failure
0.000 0.717 0.282
E07.1 Dyshormogenetic goitre
0.000 0.718 0.282
E07.0 Hypersecretion of calcitonin
0.000 0.718 0.282
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.720 0.279
E50.9 Vitamin A deficiency, unspecified
0.000 0.721 0.279
E50.8 Other manifestations of vitamin A deficiency
0.000 0.721 0.279
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.721 0.279
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.721 0.279
E50.5 Vitamin A deficiency with night blindness
0.000 0.721 0.279
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.721 0.279
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.721 0.279
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.721 0.279
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.721 0.279
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.721 0.279
E51.9 Thiamine deficiency, unspecified
0.000 0.721 0.279
E51.8 Other manifestations of thiamine deficiency
0.000 0.721 0.279
E51.2 Wernicke's encephalopathy
0.000 0.721 0.279
E51.1 Beriberi
0.000 0.721 0.279
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.721 0.279
E64.8 Sequelae of other nutritional deficiencies
0.000 0.721 0.279
E64.3 Sequelae of rickets
0.000 0.721 0.279
E64.2 Sequelae of vitamin C deficiency
0.000 0.721 0.279
E64.1 Sequelae of vitamin A deficiency
0.000 0.721 0.279
E64.0 Sequelae of protein-energy malnutrition
0.000 0.721 0.279
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.730 0.270
E26.0 Primary hyperaldosteronism
0.000 0.739 0.261
E53.1 Pyridoxine deficiency
0.000 0.739 0.261
E53.0 Riboflavin deficiency
0.000 0.739 0.261
E63.8 Other specified nutritional deficiencies
0.000 0.753 0.247
E63.1 Imbalance of constituents of food intake
0.000 0.753 0.247
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.753 0.247
E55.0 Rickets, active
0.000 0.759 0.241
E65-E68 Obesity and other hyperalimentation
0.000 0.764 0.235
E07.8 Other specified disorders of thyroid
0.000 0.774 0.226
E07.9 Disorder of thyroid, unspecified
0.000 0.779 0.220
E63.9 Nutritional deficiency, unspecified
0.001 0.797 0.202
E83 Disorders of mineral metabolism
0.201 0.799 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.807 0.193
E55.9 Vitamin D deficiency, unspecified
0.000 0.811 0.189
E67 Other hyperalimentation
0.000 0.831 0.169
E68 Sequelae of hyperalimentation
0.000 0.831 0.169
E11 Non-insulin-dependent diabetes mellitus
0.000 0.836 0.164
E83.9 Disorder of mineral metabolism, unspecified
0.162 0.838 0.000
E83.8 Other disorders of mineral metabolism
0.144 0.856 0.000
E83.2 Disorders of zinc metabolism
0.144 0.856 0.000
E83.0 Disorders of copper metabolism
0.144 0.856 0.000
E83.3 Disorders of phosphorus metabolism
0.144 0.856 0.000
E11.0 With coma
0.000 0.871 0.129
E06.3 Autoimmune thyroiditis
0.000 0.873 0.126
E11.6 With other specified complications
0.000 0.874 0.126
E11.8 With unspecified complications
0.000 0.875 0.125
E67.8 Other specified hyperalimentation
0.000 0.878 0.121
E67.3 Hypervitaminosis D
0.000 0.878 0.121
E67.2 Megavitamin-B6 syndrome
0.000 0.878 0.121
E67.1 Hypercarotenaemia
0.000 0.878 0.121
E67.0 Hypervitaminosis A
0.000 0.878 0.121
E11.7 With multiple complications
0.000 0.882 0.118
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.882 0.117
J31.0 Chronic rhinitis
0.000 0.882 0.118
E11.5 With peripheral circulatory complications
0.000 0.888 0.112
E11.2 With renal complications
0.000 0.890 0.110
E11.1 With ketoacidosis
0.000 0.905 0.095
E83.4 Disorders of magnesium metabolism
0.090 0.910 0.000
E04 Other non-toxic goitre
0.001 0.913 0.086
E21.4 Other specified disorders of parathyroid gland
0.000 0.915 0.084
E21.2 Other hyperparathyroidism
0.000 0.919 0.081
E65 Localised adiposity
0.001 0.921 0.078
E83.5 Disorders of calcium metabolism
0.077 0.923 0.000
K90-K93 Other diseases of the digestive system
0.000 0.923 0.077
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.924 0.076
E03.9 Hypothyroidism, unspecified
0.000 0.925 0.075
E11.4 With neurological complications
0.000 0.926 0.074
E11.9 Without complications
0.000 0.934 0.066
E04.9 Non-toxic goitre, unspecified
0.000 0.935 0.065
E21.5 Disorder of parathyroid gland, unspecified
0.001 0.937 0.063
E04.8 Other specified non-toxic goitre
0.001 0.937 0.062
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.944 0.056
J31 Chronic rhinitis, nasopharyngitis and pharyngitis
0.000 0.945 0.055
E66 Obesity
0.000 0.947 0.053
E21.3 Hyperparathyroidism, unspecified
0.000 0.949 0.051
E66.0 Obesity due to excess calories
0.000 0.957 0.043
J31.2 Chronic pharyngitis
0.000 0.958 0.042
J31.1 Chronic nasopharyngitis
0.000 0.959 0.041
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.000 0.960 0.040
K93.1 Megacolon in Chagas' disease
0.000 0.960 0.040
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.000 0.960 0.040
E66.1 Drug-induced obesity
0.000 0.961 0.038
K91 Postprocedural disorders of digestive system, not elsewhere classified
0.000 0.964 0.036
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.967 0.033
E04.0 Non-toxic diffuse goitre
0.001 0.968 0.031
H90.2 Conductive hearing loss, unspecified
0.000 0.969 0.031
K91.3 Postoperative intestinal obstruction
0.000 0.971 0.029
K91.2 Postsurgical malabsorption, not elsewhere classified
0.000 0.971 0.029
T43.0 Tricyclic and tetracyclic antidepressants
0.029 0.971 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.029 0.971 0.000
K91.1 Postgastric surgery syndromes
0.000 0.972 0.028
K91.9 Postprocedural disorder of digestive system, unspecified
0.000 0.972 0.028
H90 Conductive and sensorineural hearing loss
0.000 0.972 0.028
H90.5 Sensorineural hearing loss, unspecified
0.000 0.974 0.026
T36-T50 Poisoning by drugs, medicaments and biological substances
0.025 0.975 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.025 0.975 0.000
E11.3 With ophthalmic complications
0.000 0.975 0.025
H90.3 Sensorineural hearing loss, bilateral
0.000 0.975 0.025
T43.5 Other and unspecified antipsychotics and neuroleptics
0.025 0.975 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.024 0.976 0.000
H90.8 Mixed conductive and sensorineural hearing loss, unspecified
0.000 0.977 0.023
E53.8 Deficiency of other specified B group vitamins
0.001 0.977 0.022
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.023 0.977 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.022 0.978 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.022 0.978 0.000
T36 Poisoning by systemic antibiotics
0.022 0.978 0.000
T39.0 Salicylates
0.022 0.978 0.000
H90.6 Mixed conductive and sensorineural hearing loss, bilateral
0.000 0.978 0.022
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.978 0.022
T43.9 Psychotropic drug, unspecified
0.021 0.978 0.000
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.979 0.021
K91.5 Postcholecystectomy syndrome
0.000 0.979 0.021
T45.0 Antiallergic and antiemetic drugs
0.021 0.979 0.000
N30.8 Other cystitis
0.000 0.979 0.021
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.021 0.979 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.021 0.979 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.021 0.979 0.000
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.980 0.020
T43.6 Psychostimulants with abuse potential
0.020 0.980 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.020 0.980 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.019 0.981 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.019 0.981 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.019 0.981 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.019 0.981 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.018 0.981 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.018 0.982 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.018 0.982 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.018 0.982 0.000
T42.4 Benzodiazepines
0.018 0.982 0.000
T36.4 Tetracyclines
0.018 0.982 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.018 0.982 0.000
T36.0 Penicillins
0.018 0.982 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.018 0.982 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.017 0.982 0.000
T36.3 Macrolides
0.017 0.983 0.000
T45.2 Vitamins, not elsewhere classified
0.017 0.983 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.017 0.983 0.000
K91.4 Colostomy and enterostomy malfunction
0.000 0.983 0.017
T45.9 Primarily systemic and haematological agent, unspecified
0.016 0.983 0.000
T45.8 Other primarily systemic and haematological agents
0.016 0.983 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.016 0.983 0.000
T45.6 Fibrinolysis-affecting drugs
0.016 0.983 0.000
T45.4 Iron and its compounds
0.016 0.983 0.000
T45.3 Enzymes, not elsewhere classified
0.016 0.983 0.000
T42.1 Iminostilbenes
0.016 0.984 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.016 0.984 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.016 0.984 0.000
T42.3 Barbiturates
0.016 0.984 0.000
T42.2 Succinimides and oxazolidinediones
0.016 0.984 0.000
T39.4 Antirheumatics, not elsewhere classified
0.016 0.984 0.000
T39.2 Pyrazolone derivatives
0.016 0.984 0.000
T36.9 Systemic antibiotic, unspecified
0.016 0.984 0.000
T36.8 Other systemic antibiotics
0.016 0.984 0.000
T36.7 Antifungal antibiotics, systemically used
0.016 0.984 0.000
T36.6 Rifamycins
0.016 0.984 0.000
T36.5 Aminoglycosides
0.016 0.984 0.000
T36.2 Chloramphenicol group
0.016 0.984 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.016 0.984 0.000
I83.9 Varicose veins of lower extremities without ulcer or inflammation
0.016 0.984 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.016 0.984 0.000
K91.0 Vomiting following gastro-intestinal surgery
0.000 0.984 0.016
T46.1 Calcium-channel blockers
0.015 0.985 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.015 0.985 0.000
T48.5 Anti-common-cold drugs
0.015 0.985 0.000
T48.4 Expectorants
0.015 0.985 0.000
T48.3 Antitussives
0.015 0.985 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.015 0.985 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.015 0.985 0.000
T48.0 Oxytocic drugs
0.015 0.985 0.000
H90.0 Conductive hearing loss, bilateral
0.000 0.985 0.015
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.015 0.985 0.000
E04.1 Non-toxic single thyroid nodule
0.001 0.985 0.014
C43.6 Malignant melanoma of upper limb, including shoulder
0.000 0.985 0.015
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.015 0.985 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.015 0.985 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.015 0.985 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.014 0.985 0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified
0.000 0.985 0.015
T46.5 Other antihypertensive drugs, not elsewhere classified
0.014 0.986 0.000
T45.5 Anticoagulants
0.014 0.986 0.000
T42.0 Hydantoin derivatives
0.014 0.986 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.014 0.986 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.014 0.986 0.000
T46.7 Peripheral vasodilators
0.014 0.986 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.014 0.986 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.014 0.986 0.000
T50.8 Diagnostic agents
0.014 0.986 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.014 0.986 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.014 0.986 0.000
T47.7 Emetics
0.014 0.986 0.000
T47.6 Antidiarrhoeal drugs
0.014 0.986 0.000
T47.5 Digestants
0.014 0.986 0.000
T47.3 Saline and osmotic laxatives
0.014 0.986 0.000
T47.2 Stimulant laxatives
0.014 0.986 0.000
T47.0 Histamine H(2)-receptor antagonists
0.014 0.986 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.014 0.986 0.000
T37.5 Antiviral drugs
0.014 0.986 0.000
T37.4 Anthelminthics
0.014 0.986 0.000
T37.3 Other antiprotozoal drugs
0.014 0.986 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.014 0.986 0.000
T37.1 Antimycobacterial drugs
0.014 0.986 0.000
T37.0 Sulphonamides
0.014 0.986 0.000
T50.1 Loop [high-ceiling] diuretics
0.014 0.986 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.014 0.986 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.014 0.986 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.013 0.986 0.000
T41.5 Therapeutic gases
0.013 0.986 0.000
T41.4 Anaesthetic, unspecified
0.013 0.986 0.000
T41.3 Local anaesthetics
0.013 0.986 0.000
T41.2 Other and unspecified general anaesthetics
0.013 0.986 0.000
T41.1 Intravenous anaesthetics
0.013 0.986 0.000
T41.0 Inhaled anaesthetics
0.013 0.986 0.000
C43 Malignant melanoma of skin
0.000 0.986 0.014
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.013 0.987 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.013 0.987 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.013 0.987 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.013 0.987 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.013 0.987 0.000
T44.0 Anticholinesterase agents
0.013 0.987 0.000
T49.9 Topical agent, unspecified
0.013 0.987 0.000
T49.8 Other topical agents
0.013 0.987 0.000
T49.7 Dental drugs, topically applied
0.013 0.987 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.013 0.987 0.000
T49.5 Ophthalmological drugs and preparations
0.013 0.987 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.013 0.987 0.000
T49.3 Emollients, demulcents and protectants
0.013 0.987 0.000
T49.2 Local astringents and local detergents
0.013 0.987 0.000
T49.1 Antipruritics
0.013 0.987 0.000
C43.5 Malignant melanoma of trunk
0.000 0.987 0.013
E21.0 Primary hyperparathyroidism
0.001 0.987 0.013
T50.7 Analeptics and opioid receptor antagonists
0.013 0.987 0.000
T50.5 Appetite depressants
0.013 0.987 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.013 0.987 0.000
T50.0 Mineralocorticoids and their antagonists
0.013 0.987 0.000
C43.3 Malignant melanoma of other and unspecified parts of face
0.000 0.987 0.013
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.013 0.987 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.013 0.987 0.000
T38.9 Other and unspecified hormone antagonists
0.013 0.987 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.013 0.987 0.000
T38.7 Androgens and anabolic congeners
0.013 0.987 0.000
T38.5 Other oestrogens and progestogens
0.013 0.987 0.000
T38.4 Oral contraceptives
0.013 0.987 0.000
T38.2 Antithyroid drugs
0.013 0.987 0.000
T38.0 Glucocorticoids and synthetic analogues
0.013 0.987 0.000
T47.4 Other laxatives
0.013 0.987 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.013 0.987 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.013 0.987 0.000
E66.8 Other obesity
0.000 0.987 0.013
T50.4 Drugs affecting uric acid metabolism
0.013 0.987 0.000
C77.4 Inguinal and lower limb lymph nodes
0.000 0.987 0.013
T39.1 4-Aminophenol derivatives
0.013 0.987 0.000
S52.60 Fracture of lower end of both ulna and radius (closed)
0.000 0.988 0.012
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.012 0.988 0.000
T38.1 Thyroid hormones and substitutes
0.012 0.988 0.000
C43.9 Malignant melanoma of skin, unspecified
0.000 0.988 0.012
T43.2 Other and unspecified antidepressants
0.011 0.989 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.011 0.989 0.000
C43.4 Malignant melanoma of scalp and neck
0.000 0.989 0.011
X41.9 Unspecified place
0.011 0.989 0.000
C43.8 Overlapping malignant melanoma of skin
0.000 0.990 0.010
C43.0 Malignant melanoma of lip
0.000 0.990 0.010
O43.8 Other placental disorders
0.000 0.990 0.010
T46.4 Angiotensin-converting-enzyme inhibitors
0.010 0.990 0.000
H26.9 Cataract, unspecified
0.000 0.990 0.010
H43.8 Other disorders of vitreous body
0.000 0.990 0.010
I83.1 Varicose veins of lower extremities with inflammation
0.009 0.991 0.000
I05.9 Mitral valve disease, unspecified
0.000 0.991 0.009
I83 Varicose veins of lower extremities
0.009 0.991 0.000
H43 Disorders of vitreous body
0.000 0.991 0.009
A87.9 Viral meningitis, unspecified
0.000 0.991 0.009
C43.2 Malignant melanoma of ear and external auricular canal
0.000 0.992 0.008
C43.1 Malignant melanoma of eyelid, including canthus
0.000 0.992 0.008
M21.57 Acquired clawhand, clubhand, clawfoot and clubfoot (Ankle and foot)
0.008 0.992 0.000
H43.1 Vitreous haemorrhage
0.000 0.992 0.008

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.